PATENT CLAIM ANALYSIS

Application Number: 16131641
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "400000"]

Abstract:
Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.

Claim (Index 46):
The method of claim  1 , wherein the spray delivers about 5 mg naloxone.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.27273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15268066', '15183441', '15428705', '15589090', '14942344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.826963276336217
- 35 USC 102 Novelty (BERT): 0.6112643474351716
- Combined Prediction Score: 0.8053933834461126
- Mean Citation Score: 521.2009999999998
- Max Citation Score: 543.52
- Similarity Product: 520.4987239265441

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test